Pleotropic role of RNA binding protein CELF2 in autophagy induction.


Journal

Molecular carcinogenesis
ISSN: 1098-2744
Titre abrégé: Mol Carcinog
Pays: United States
ID NLM: 8811105

Informations de publication

Date de publication:
08 2019
Historique:
received: 07 02 2019
revised: 27 03 2019
accepted: 08 04 2019
pubmed: 26 4 2019
medline: 7 11 2019
entrez: 26 4 2019
Statut: ppublish

Résumé

We previously reported that ionizing radiation (IR) mediates cell death through the induction of CUGBP elav-like family member 2 (CELF2), a tumor suppressor. CELF2 is an RNA binding protein that modulates mRNA stability and translation. Since IR induces autophagy, we hypothesized that CELF2 regulates autophagy-mediated colorectal cancer (CRC) cell death. For clinical relevance, we determined CELF2 levels in The Cancer Genome Atlas (TCGA). Role of CELF2 in radiation response was carried out in CRC cell lines by immunoblotting, immunofluorescence, autophagic vacuole analyses, RNA stability assay, quantitative polymerase chain reaction and electron microscopy. In vivo studies were performed in a xenograft tumor model. TCGA analyses demonstrated that compared to normal tissue, CELF2 is expressed at significantly lower levels in CRC, and is associated with better overall 5-year survival in patients receiving radiation. Mechanistically, CELF2 increased levels of critical components of the autophagy cascade including Beclin-1, ATG5, and ATG12 by modulating mRNA stability. CELF2 also increased autophagic flux in CRC. IR significantly induced autophagy in CRC which correlates with increased levels of CELF2 and autophagy associated proteins. Silencing CELF2 with siRNA, mitigated IR induced autophagy. Moreover, knockdown of CELF2 in vivo conferred tumor resistance to IR. These studies elucidate an unrecognized role for CELF2 in inducing autophagy and potentiating the effects of radiotherapy in CRC.

Identifiants

pubmed: 31020708
doi: 10.1002/mc.23023
pmc: PMC6602857
mid: NIHMS1023658
doi:

Substances chimiques

ATG12 protein, human 0
ATG5 protein, human 0
Autophagy-Related Protein 12 0
Autophagy-Related Protein 5 0
BECN1 protein, human 0
Beclin-1 0
CELF Proteins 0
CELF2 protein, human 0
Nerve Tissue Proteins 0
RNA, Messenger 0
RNA, Small Interfering 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1400-1409

Subventions

Organisme : NCI NIH HHS
ID : P30 CA168524
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA227838
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090216
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA182872
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA190291
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI138323
Pays : United States

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Oncogene. 2010 Feb 11;29(6):781-8
pubmed: 19946329
Am J Pathol. 2007 Jan;170(1):75-86
pubmed: 17200184
Immunogastroenterology. 2012;1(1):27-33
pubmed: 23795348
Langenbecks Arch Surg. 2016 Feb;401(1):99-111
pubmed: 26691217
Nat Cell Biol. 2006 Oct;8(10):1124-32
pubmed: 16998475
Nat Commun. 2013;4:2130
pubmed: 23945651
Autophagy. 2009 Apr;5(3):329-38
pubmed: 19066463
Sci Rep. 2017 Jun 14;7(1):3471
pubmed: 28615639
PLoS One. 2011 Feb 11;6(2):e16958
pubmed: 21347286
Cancer Res. 2000 Sep 1;60(17):4705-8
pubmed: 10987272
Nat Cell Biol. 2004 Dec;6(12):1221-8
pubmed: 15558033
Methods. 2002 Feb;26(2):182-90
pubmed: 12054895
Cell Death Differ. 2015 Jan;22(1):58-73
pubmed: 25236395
Int J Mol Sci. 2016 Feb 27;17(3):310
pubmed: 26927092
Cell. 2007 Dec 14;131(6):1137-48
pubmed: 18083103
J Cell Physiol. 2013 Jan;228(1):1-8
pubmed: 22585676
Genes Dev. 2015 Oct 1;29(19):2054-66
pubmed: 26443849
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Dev Dyn. 2013 Jun;242(6):767-77
pubmed: 23468433
Mol Cell. 2003 Jan;11(1):113-26
pubmed: 12535526
Am J Physiol Gastrointest Liver Physiol. 2008 May;294(5):G1235-44
pubmed: 18325984
Oncotarget. 2016 Mar 15;7(11):12937-50
pubmed: 26887050
Cell Death Differ. 2009 Jul;16(7):1018-29
pubmed: 19390558
Cell Death Differ. 2009 Aug;16(8):1093-107
pubmed: 19373242
Eur J Cell Biol. 1995 Jan;66(1):3-14
pubmed: 7750517
Cell Rep. 2014 Apr 24;7(2):488-500
pubmed: 24703838

Auteurs

Jacob New (J)

Department of Anatomy & Cell Biology, University of Kansas Medical Center, Kansas, Kansas.
Department of Otolaryngology, University of Kansas Medical Center, Kansas, Kansas.

Dharmalingam Subramaniam (D)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Satish Ramalingam (S)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Jonathan Enders (J)

Department of Anatomy & Cell Biology, University of Kansas Medical Center, Kansas, Kansas.

Afreen Asif Ali Sayed (AAA)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Sivapriya Ponnurangam (S)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

David Standing (D)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Prabhu Ramamoorthy (P)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Maura O'Neil (M)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas, Kansas.

Dan A Dixon (DA)

Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas.

Subhrajit Saha (S)

Department of Radiation Oncology, University of Kansas Medical Center, Kansas, Kansas.

Shahid Umar (S)

Department of General Surgery, University of Kansas Medical Center, Kansas, Kansas.

Sumedha Gunewardena (S)

Department of Molecular Integrative Physiology, University of Kansas Medical Center, Kansas, Kansas.

Roy A Jensen (RA)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas, Kansas.

Sufi Mary Thomas (SM)

Department of Anatomy & Cell Biology, University of Kansas Medical Center, Kansas, Kansas.
Department of Otolaryngology, University of Kansas Medical Center, Kansas, Kansas.
Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Shrikant Anant (S)

Department of Cancer Biology, University of Kansas Medical Center, Kansas, Kansas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH